Paul Heroux PhD Response to the FDA Report on Cell Phone Radiation
The FDA Report stated,” We do not know if there is a causal effect or if these results are due to weakening of the immune response due to animal stress from cyclic heating and thermoregulation decline in aging animals leading to whole-body temperature increase, possible sleep disruption due to the cyclic heating, or due to an RF-specific effect that has not been identified and has an adverse effect before heating becomes the dominant safety issue.”
Response by Paul Heroux PhD
“FDA is pushing red herrings to avoid the inevitable conclusion that electromagnetic fields have important carcinogenic effects on animals below thermal levels.
There is an apparent attempt is to confuse the discussion by invoking an “immune” mechanism driven by heat and sleep disturbances, and other ghost mechanisms that would inevitably turn out to be dead ends.
These surprising comments should not distract us from (1) at least four previous spectacular animal experiments linking fields to cancer, from (2) the drastic action of fields on human cancer cells at field intensities nowhere near the thermal limit, as well as (3) the literature linking fields to reactive oxygen species and mutations.
An institution (FDA) displaying such a fundamental reluctance to acknowledge evidence should abstain from commenting on the NTP study.
The FDA Report stated,” It is possible that any form (ambient, IR, ultrasound) of cyclic whole-body heating of this magnitude may cause similar findings, but no such studies have been conducted to date.”
Response by Paul Heroux PhD
“This is a way to extend the lie about health impacts of electromagnetic fields by directing attention to some form of further investigation that would allow industry to proceed with increases in human exposures, while we await the results of yet another waste of time.”
Paul Héroux, PhD
Professor of Toxicology and Health Effects of Electromagnetism
McGill University Medicine
Department of Surgery, McGill University Health Center
